Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Identical lesion morphology in primary progressive and relapsing-remitting MS -an ultrahigh field MRI study.
The search for the target antigens of multiple sclerosis, part 2: CD8+ T cells, B cells, and antibodies in the focus of reverse-translational research.
NOVANTRONE. mitoXANTRONE for injection concentrate
Personality in multiple sclerosis (MS): impact on health, psychological well-being, coping, and overall quality of life.
Autoimmunity in visual loss.
Disease-modifying drugs reduce cortical lesion accumulation and atrophy progression in relapsing-remitting multiple sclerosis: results from a 48-month extension study.
Antibodies to MOG are transient in childhood acute disseminated encephalomyelitis.
Autoimmune Hepatitis-like reaction developing in a patient treated with Interferon beta 1a.
Attenuation of 7-ketocholesterol-induced overproduction of reactive oxygen species, apoptosis, and autophagy by dimethyl fumarate on 158N murine oligodendrocytes.
Are natural killer cells involved in multiple sclerosis etiology? Evidences from NKp46/NCR1 receptor modulation in an observational study.
Incidence of infusion-associated reactions with rituximab for treating multiple sclerosis: a retrospective analysis of patients treated at a US centre.
Alemtuzumab long-term immunologic effect: Treg suppressor function increases up to 24 months.
Gene expression analysis reveals functional pathways of glatiramer acetate activation.
Role of regulatory b cells in neuroimmunologic disorders.
Interferon-beta in pediatric multiple sclerosis patients: safety in short-term prescription.
New data from ENDORSE show positive results continued over five years with TECFIDERA® (dimethyl fumarate) in a wide range of multiple sclerosis patients
A newborn with Pierre Robin sequence after preconceptional mitoxantrone exposure of a female with multiple sclerosis.
Tolerability and Pulmonary Pharmacodynamic Effects During Treatment Initiation of Once-Daily Oral Fingolimod in Subjects With Moderate Asthma.
Immune competence after alemtuzumab treatment of multiple sclerosis.
Clinical features of neuromyelitis optica in children: US Network of Pediatric MS Centers report.
Ethnicity and prevalence of multiple sclerosis in east London.
Equivalence of Generic Glatiramer Acetate in Multiple Sclerosis: A Randomized Clinical Trial.
Genmab announces results of ofatumumab Phase II study in multiple sclerosis
Lithium Controls Central Nervous System Autoimmunity through Modulation of IFN-γ Signaling.
Studying both sexes: a guiding principle for biomedicine.

Pages